Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -92.7% | -33.9% | 1 / 3 | +4.4% | -12.43 pp | -7.35 pp | +3.0% | 0.56 | 12.86 | 693 | +4,4% | 9,9 | −83,0% | 12.86 | 9.95 | +29,3% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.860 (close price on 2026-10-19)EPS (TTM): 611,1
Financial charts
1.Revenue & growth
VND bn693Q2/26
1.Revenue & growth
VND bn693Q2/26
2.Profit & growth
VND bn4,19Q2/26
3.Profit mix (Penman)
VND bn73,2Q2/26
4.Margins & cost structure
%9.7%Q2/26
5.Returns & cash cycle
% · days4.0%Q2/26
6.Earnings quality & cash
VND bn373Q2/26
7.Asset structure
VND bn3.263Q2/26
8.Funding & debt health
VND bn · times3.263Q2/26
9.Revenue backlog
VND bn91,7Q2/26
10.Valuation
times · %13,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %47Q2/26
Adjusted EPS growth, latest quarter
-92.7%
Average adjusted EPS growth, 3 quarters
-33.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26